Peri-mitral atrial flutter in patients with atrial fibrillation ablation

Seiichiro Matsuo1, Matthew Wright, Sébastien Knecht

  • 1Hôpital Cardiologique du Haut-Lévêque and Université Victor Segalen Bordeaux II, Bordeaux, France. mattsuu@tc4.so-net.ne.jp.

Heart Rhythm
|December 8, 2009
PubMed
Abstract

Insights

Peri-mitral atrial flutter (PMFL) ablation successfully terminates the arrhythmia in most patients. However, supplemental ablation is crucial to ensure complete block and prevent recurrence, as the initial procedure can be proarrhythmic.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Cardiac Ablation

Background:

  • Peri-mitral atrial flutter (PMFL) is a common complication in patients undergoing atrial fibrillation (AF) ablation.
  • Understanding PMFL's characteristics is crucial for managing patients post-AF ablation.

Purpose of the Study:

  • To determine the electrophysiologic characteristics of PMFL.
  • To assess procedural success and medium-term outcomes of PMFL ablation.

Main Methods:

  • Study included 50 consecutive patients with PMFL post-AF ablation.
  • PMFL ablation involved creating a linear lesion from the mitral annulus to the left inferior pulmonary vein.
  • Mitral isthmus (MI) ablation was assessed for its role in PMFL incidence and management.

Main Results:

  • PMFL incidence was higher in patients with prior MI ablation.
  • Seventy percent of PMFLs were terminated by ablation, requiring supplemental procedures for bidirectional block in 66%.
  • Mitral isthmus block was achieved in 92% of patients, with 96% remaining free from PMFL at 19-month follow-up.

Conclusions:

  • Mitral isthmus ablation can terminate PMFL but carries a risk of being proarrhythmic.
  • Supplemental ablation is necessary to achieve bidirectional block and ensure long-term success.
  • PMFL ablation is effective for achieving freedom from arrhythmia in the medium term.

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Disturbances in Heart Rhythm01:29

Disturbances in Heart Rhythm

Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.